This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

AI medical device mechanism, public data highlighted in reforms in China's Shenzhen

( June 12, 2025, 08:59 GMT | Official Statement) -- MLex Summary: Shenzhen, China’s innovation hub, will develop a mechanism for the admission and application of AI-assisted medical devices, establishing rules and standards for data collection, integrated sharing and compliant use in line with reform and innovation policies. The initiative was outlined in a set of central-government opinions on advancing reform, innovation and opening up as part of the city’s comprehensive reform pilot. Simultaneously, the city will promote graded and classified public data access in sectors such as transportation, geography, remote sensing, meteorology and healthcare, while improving management systems and service standards. Additionally, Shenzhen will boost data security governance and explore a secure, efficient mechanism for cross-border data flows. Below please find the statement: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login